QuantRx Biomedical Corporation (QTXB)
USD 0.0
(400.0%)
USD 0.0
(400.0%)
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2022 | - USD | -100.0% |
| 2021 | 5950.00 USD | -89.27% |
| 2020 | 55.42 Thousand USD | -59.64% |
| 2019 | 137.35 Thousand USD | -76.39% |
| 2018 | 581.78 Thousand USD | -58.17% |
| 2017 | 1.39 Million USD | 554.17% |
| 2016 | 212.6 Thousand USD | -40.7% |
| 2015 | 358.52 Thousand USD | -26.91% |
| 2014 | 490.51 Thousand USD | 23.26% |
| 2013 | 397.94 Thousand USD | -16.05% |
| 2012 | 474.02 Thousand USD | -19.14% |
| 2011 | 586.23 Thousand USD | -54.97% |
| 2010 | 1.3 Million USD | -3.1% |
| 2009 | 1.34 Million USD | -60.54% |
| 2008 | 3.4 Million USD | -6.74% |
| 2007 | 3.65 Million USD | -15.35% |
| 2006 | 4.31 Million USD | 226.25% |
| 2005 | 1.32 Million USD | 604.66% |
| 2004 | 187.59 Thousand USD | 102.15% |
| 2003 | 92.8 Thousand USD | -15.02% |
| 2002 | 109.2 Thousand USD | -72.0% |
| 2001 | 390 Thousand USD | -33.9% |
| 2000 | 590 Thousand USD | -56.62% |
| 1999 | 1.36 Million USD | -28.04% |
| 1998 | 1.89 Million USD | -4.06% |
| 1997 | 1.97 Million USD | -0.51% |
| 1996 | 1.98 Million USD | -42.94% |
| 1995 | 3.47 Million USD | -25.85% |
| 1994 | 4.68 Million USD | 0.0% |
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2023 Q3 | - USD | 0.0% |
| 2023 Q1 | - USD | 0.0% |
| 2023 Q2 | - USD | 0.0% |
| 2022 Q1 | 5920.00 USD | -0.5% |
| 2022 Q2 | 4644.00 USD | -21.55% |
| 2022 FY | - USD | -100.0% |
| 2022 Q4 | - USD | -100.0% |
| 2022 Q3 | 5383.00 USD | 15.91% |
| 2021 Q1 | 48.49 Thousand USD | -12.51% |
| 2021 FY | 5950.00 USD | -89.27% |
| 2021 Q4 | 5950.00 USD | -71.74% |
| 2021 Q3 | 21.05 Thousand USD | -24.16% |
| 2021 Q2 | 27.75 Thousand USD | -42.77% |
| 2020 Q4 | 55.42 Thousand USD | -9.53% |
| 2020 FY | 55.42 Thousand USD | -59.64% |
| 2020 Q1 | 111.97 Thousand USD | -18.47% |
| 2020 Q2 | 83.41 Thousand USD | -25.51% |
| 2020 Q3 | 61.26 Thousand USD | -26.55% |
| 2019 Q4 | 137.35 Thousand USD | -64.23% |
| 2019 Q1 | 531.43 Thousand USD | -8.66% |
| 2019 Q2 | 440.39 Thousand USD | -17.13% |
| 2019 Q3 | 383.96 Thousand USD | -12.81% |
| 2019 FY | 137.35 Thousand USD | -76.39% |
| 2018 FY | 581.78 Thousand USD | -58.17% |
| 2018 Q1 | 1.32 Million USD | -4.96% |
| 2018 Q4 | 581.78 Thousand USD | -47.65% |
| 2018 Q3 | 1.11 Million USD | -7.43% |
| 2018 Q2 | 1.2 Million USD | -9.18% |
| 2017 Q3 | 190.05 Thousand USD | -15.44% |
| 2017 Q1 | 236.92 Thousand USD | 11.44% |
| 2017 FY | 1.39 Million USD | 554.17% |
| 2017 Q4 | 1.39 Million USD | 631.79% |
| 2017 Q2 | 224.76 Thousand USD | -5.13% |
| 2016 FY | 212.6 Thousand USD | -40.7% |
| 2016 Q3 | 222.2 Thousand USD | -20.23% |
| 2016 Q2 | 278.56 Thousand USD | -13.47% |
| 2016 Q4 | 212.6 Thousand USD | -4.32% |
| 2016 Q1 | 321.94 Thousand USD | -10.2% |
| 2015 FY | 358.52 Thousand USD | -26.91% |
| 2015 Q4 | 358.52 Thousand USD | -9.41% |
| 2015 Q1 | 436.76 Thousand USD | -10.96% |
| 2015 Q2 | 450.75 Thousand USD | 3.2% |
| 2015 Q3 | 395.78 Thousand USD | -12.2% |
| 2014 Q3 | 550.59 Thousand USD | 48.09% |
| 2014 Q2 | 371.79 Thousand USD | -20.34% |
| 2014 FY | 490.51 Thousand USD | 23.26% |
| 2014 Q4 | 490.51 Thousand USD | -10.91% |
| 2014 Q1 | 466.75 Thousand USD | 17.29% |
| 2013 FY | 397.94 Thousand USD | -16.05% |
| 2013 Q1 | 473.46 Thousand USD | -0.12% |
| 2013 Q2 | 438.38 Thousand USD | -7.41% |
| 2013 Q3 | 428.68 Thousand USD | -2.21% |
| 2013 Q4 | 397.94 Thousand USD | -7.17% |
| 2012 Q1 | 574.48 Thousand USD | -2.0% |
| 2012 Q3 | 610.11 Thousand USD | 7.01% |
| 2012 Q4 | 474.02 Thousand USD | -22.31% |
| 2012 FY | 474.02 Thousand USD | -19.14% |
| 2012 Q2 | 570.13 Thousand USD | -0.76% |
| 2011 FY | 586.23 Thousand USD | -54.97% |
| 2011 Q4 | 586.23 Thousand USD | -6.07% |
| 2011 Q3 | 624.12 Thousand USD | 6.37% |
| 2011 Q2 | 586.77 Thousand USD | -11.22% |
| 2011 Q1 | 660.96 Thousand USD | -49.23% |
| 2010 Q2 | 1.43 Million USD | 37.38% |
| 2010 Q4 | 1.3 Million USD | -11.04% |
| 2010 FY | 1.3 Million USD | -3.1% |
| 2010 Q3 | 1.46 Million USD | 2.33% |
| 2010 Q1 | 1.04 Million USD | -22.52% |
| 2009 Q3 | 2.19 Million USD | 48.14% |
| 2009 Q1 | 3.7 Million USD | 8.72% |
| 2009 FY | 1.34 Million USD | -60.54% |
| 2009 Q4 | 1.34 Million USD | -38.73% |
| 2009 Q2 | 1.48 Million USD | -60.01% |
| 2008 Q4 | 3.4 Million USD | -3.73% |
| 2008 Q1 | 3.63 Million USD | -0.5% |
| 2008 Q2 | 3.54 Million USD | -2.46% |
| 2008 Q3 | 3.53 Million USD | -0.18% |
| 2008 FY | 3.4 Million USD | -6.74% |
| 2007 Q3 | 3.47 Million USD | -18.42% |
| 2007 Q4 | 3.65 Million USD | 4.91% |
| 2007 Q2 | 4.26 Million USD | -38.52% |
| 2007 FY | 3.65 Million USD | -15.35% |
| 2007 Q1 | 6.93 Million USD | 60.88% |
| 2006 FY | 4.31 Million USD | 226.25% |
| 2006 Q1 | 4.64 Million USD | 251.73% |
| 2006 Q2 | 4.06 Million USD | -12.65% |
| 2006 Q3 | 3.57 Million USD | -11.98% |
| 2006 Q4 | 4.31 Million USD | 20.64% |
| 2005 Q4 | 1.32 Million USD | 102.17% |
| 2005 Q2 | 898.18 Thousand USD | 534.79% |
| 2005 Q3 | 653.88 Thousand USD | -27.2% |
| 2005 Q1 | 141.49 Thousand USD | -24.58% |
| 2005 FY | 1.32 Million USD | 604.66% |
| 2004 FY | 187.59 Thousand USD | 102.15% |
| 2004 Q4 | 187.59 Thousand USD | 0.0% |
| 2003 FY | 92.8 Thousand USD | -15.02% |
| 2003 Q4 | 90 Thousand USD | 0.0% |
| 2002 Q1 | 370 Thousand USD | -5.13% |
| 2002 Q4 | 110 Thousand USD | 0.0% |
| 2002 FY | 109.2 Thousand USD | -72.0% |
| 2001 FY | 390 Thousand USD | -33.9% |
| 2001 Q1 | 530 Thousand USD | -10.17% |
| 2001 Q4 | 390 Thousand USD | -13.33% |
| 2001 Q3 | 450 Thousand USD | -6.25% |
| 2001 Q2 | 480 Thousand USD | -9.43% |
| 2000 Q2 | 930 Thousand USD | -35.42% |
| 2000 Q4 | 590 Thousand USD | -33.71% |
| 2000 Q3 | 890 Thousand USD | -4.3% |
| 2000 Q1 | 1.44 Million USD | 10.77% |
| 2000 FY | 590 Thousand USD | -56.62% |
| 1999 Q2 | 1.21 Million USD | -4.72% |
| 1999 Q1 | 1.27 Million USD | -32.09% |
| 1999 Q3 | 1.51 Million USD | 24.79% |
| 1999 Q4 | 1.3 Million USD | -13.91% |
| 1999 FY | 1.36 Million USD | -28.04% |
| 1998 FY | 1.89 Million USD | -4.06% |
| 1998 Q3 | 1.36 Million USD | -20.0% |
| 1998 Q2 | 1.7 Million USD | 16.44% |
| 1998 Q4 | 1.87 Million USD | 37.5% |
| 1998 Q1 | 1.46 Million USD | -25.89% |
| 1997 Q3 | 3.14 Million USD | -17.15% |
| 1997 Q4 | 1.97 Million USD | -37.26% |
| 1997 Q2 | 3.79 Million USD | 63.36% |
| 1997 Q1 | 2.32 Million USD | 17.17% |
| 1997 FY | 1.97 Million USD | -0.51% |
| 1996 Q3 | 1.7 Million USD | 6.25% |
| 1996 Q1 | 2.85 Million USD | -17.87% |
| 1996 FY | 1.98 Million USD | -42.94% |
| 1996 Q2 | 1.6 Million USD | -43.86% |
| 1996 Q4 | 1.98 Million USD | 16.47% |
| 1995 Q4 | 3.47 Million USD | -16.59% |
| 1995 Q1 | 3.7 Million USD | -20.94% |
| 1995 Q2 | 4.83 Million USD | 30.54% |
| 1995 Q3 | 4.16 Million USD | -13.87% |
| 1995 FY | 3.47 Million USD | -25.85% |
| 1994 FY | 4.68 Million USD | 0.0% |
| 1994 Q3 | 360 Thousand USD | -26.53% |
| 1994 Q2 | 490 Thousand USD | 0.0% |
| 1994 Q4 | 4.68 Million USD | 1200.0% |
| Name | Total Assets | Total Assets Difference |
|---|---|---|
| American Medical Technologies Inc. | 1.83 Million USD | 100.0% |
| Ansell Limited | 3.23 Billion USD | 100.0% |
| Ansell Limited | 3.24 Billion USD | 100.0% |
| BG Medicine, Inc. | - USD | NaN% |
| Biotage AB (publ) | 488.98 Million USD | 100.0% |
| BioLife Sciences Inc. | - USD | NaN% |
| CB Scientific, Inc. | 300.36 Thousand USD | 100.0% |
| Psykey, Inc. | 1.72 Million USD | 100.0% |
| ConvaTec Group Plc | 3.7 Billion USD | 100.0% |
| ConvaTec Group Plc | 3.71 Billion USD | 100.0% |
| Encision Inc. | 3.81 Million USD | 100.0% |
| Golden Valley Development, Inc | - USD | NaN% |
| Hear AtLast Holdings, Inc. | - USD | NaN% |
| Innovative MedTech Inc. | 651.88 Thousand USD | 100.0% |
| LifePoint, Inc. | 8.8 Million USD | 100.0% |
| Medite Cancer Diagnostics, Inc. | 15.95 Million USD | 100.0% |
| Paradigm Medical Industries, Inc. | 895 Thousand USD | 100.0% |
| Remedent, Inc. | 5.48 Million USD | 100.0% |
| Reflect Scientific, Inc. | 2.66 Million USD | 100.0% |
| SmileDirectClub, Inc. | 597.06 Million USD | 100.0% |
| Sector 10, Inc. | 1000.00 USD | 100.0% |
| Shandong Weigao Group Medical Polymer Company Limited | 4.74 Billion USD | 100.0% |
| SheerVision, Inc. | 837.56 Thousand USD | 100.0% |
| United Health Products, Inc. | 284.64 Thousand USD | 100.0% |
| Vasamed, Inc. | 1.6 Million USD | 100.0% |
| Wearable Health Solutions, Inc. | 223.17 Thousand USD | 100.0% |
| Yubo International Biotech Limited | 2.34 Million USD | 100.0% |